HF
RANI icon

HRT Financial’s Rani Therapeutics RANI Stock Holding History

HRT Financial’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-113,206
Closed -$56K – 3876
2025
Q3 		$56K Buy
+113,206
New +$59K ﹤0.01% 2590
2024
Q2 		– Sell
-22,587
Closed -$70K – 2937
2024
Q1 		$70K Buy
+22,587
New +$77.7K ﹤0.01% 1899
2023
Q3 		– Sell
-41,342
Closed -$170K – 2962
2023
Q2 		$170K Buy
41,342
+23,244
+128% +$108K ﹤0.01% 1884
2023
Q1 		$93K Buy
+18,098
New +$109K ﹤0.01% 2071

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

HRT Financial's RANI Position: Q4 2025 in Review

HRT Financial sold out of Rani Therapeutics (RANI) in Q4 2025, closing a stake of 113,206 shares — an estimated $56K sold.

HRT Financial first reported a position in RANI in Q1 2023 and held it in 4 quarters. The position peaked at $170K in Q2 2023. 64 funds tracked by Wall St. Rank hold RANI as of Q4 2025.

  • HRT Financial reported no remaining Rani Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 113,206 Rani Therapeutics shares in Q4 2025, an estimated $56K.
  • HRT Financial first reported a position in Rani Therapeutics in Q1 2023 and held it in 4 quarters.
  • HRT Financial's Rani Therapeutics position peaked at $170K in Q2 2023.
  • 64 funds tracked by Wall St. Rank held Rani Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.